← Back to Search

Stress Impact for Rosacea

N/A

Recruiting

Led By Kristen Metzler-Wilson, PT, PhD

Research Sponsored by Kristen Metzler-Wilson

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediate (during the single-day study). this study consists of a one-day protocol, during which this outcome is measured.

Awards & highlights

No Placebo-Only Group

Summary

This trial seeks to understand how stress can trigger rosacea symptoms to inform treatments for the 16 million Americans it affects.

Who is the study for?

This trial is for healthy males and females with mild to moderate rosacea, who are not pregnant or breastfeeding. Participants should not have any major health issues like heart or neurological disorders, no recent drug/alcohol abuse, no allergies to protocol drugs, non-smokers, and a BMI under 35.

What is being tested?

The study investigates how stressors affecting the 'fight or flight' nervous system contribute to rosacea symptoms. It aims to improve understanding of this relationship in order to develop better treatments for those suffering from rosacea.

What are the potential side effects?

Since the trial involves studying the effects of systemic and local stressors on individuals with rosacea rather than testing new medications, specific side effects are not listed but may include temporary increased redness or inflammation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediate (during the single-day study). this study consists of a one-day protocol, during which this outcome is measured.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediate (during the single-day study). this study consists of a one-day protocol, during which this outcome is measured.

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate (during the single-day study). this study consists of a one-day protocol, during which this outcome is measured. for reporting.